Human germ cell tumours: expression of γ-glutamyl transpeptidase and sensitivity to cisplatin

Por Hanigan, M H, Frierson, H F, Abeler, V M, Kaern, J, Taylor, P T
Publicado em 1999

Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status.

Por Smith-Sørensen, B., Kaern, J., Holm, R., Dørum, A., Tropé, C., Børresen-Dale, A. L.
Publicado em 1998

Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells.

Por Marth, C., Widschwendter, M., Kaern, J., Jørgensen, N. P., Windbichler, G., Zeimet, A. G., Tropé, C., Daxenbichler, G.
Publicado em 1997

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer...

Por Wagner, U, Marth, C, Largillier, R, Kaern, J, Brown, C, Heywood, M, Bonaventura, T, Vergote, I, Piccirillo, M C, Fossati, R, Gebski, V, Lauraine, E P
Publicado em 2012